A recent and exciting post from Endpoints News on the recent psilocybin trial by COMPASS Pathways. While this study was on their own synthesized version of psilocybin, the results should be reflective of naturally derived sources as well. The lead investigator claims this to be the largest controlled study of psilocybin to date:

The trial testing the COMPASS compound is the largest controlled study of psilocybin to date, said the study’s lead investigator, James Rucker of King’s College London’s Institute of Psychiatry, Psychology & Neuroscience, in a statement.

Full article can be found here:

https://endpts.com/in-a-key-step-for-psychedelic-research-magic-mushroom-compound-clears-first-clinical-safety-hurdle/